Orphan nuclear receptor nr4a1 regulates winter depression-like behavior in medaka.

Neurosci Lett

Laboratory of Animal Integrative Physiology, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Aichi 464-8601, Japan; Institute of Transformative Bio-molecules (WPI-ITbM), Nagoya University, Nagoya, Aichi 464-8601, Japan. Electronic address:

Published: September 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

About 10% of the population suffers from depression in winter at high latitude. Although it has become a serious public health issue, its underlying mechanism remains unknown and new treatments and therapies are required. As an adaptive strategy, many animals also exhibit depression-like behavior in winter. Previously, it has been reported that celastrol, a traditional Chinese medicine, can rescue winter depression-like behavior in medaka, an excellent model of winter depression. Nuclear receptor subfamily 4 group A member 1 (nr4a1, also known as nur77) is a known target of celastrol, and the signaling pathway of nr4a1 was suggested to be inactive in medaka brain during winter, implying the association of nr4a1 and winter depression-like behavior. However, the direct evidence for its involvement in winter depression-like behavior remains unclear. The present study found that nr4a1 was suppressed in the medaka brain under winter conditions. Cytosporone B, nr4a1 chemical activator, reversed winter depression-like behavior under winter conditions. Additionally, nr4a1 mutant fish generated by CRISPR/Cas9 system showed decreased sociability under summer conditions. Therefore, our results demonstrate that the seasonal regulation of nr4a1 regulates winter depression-like behavior and offers potential therapeutic target.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2023.137469DOI Listing

Publication Analysis

Top Keywords

depression-like behavior
28
winter depression-like
24
winter
12
nuclear receptor
8
nr4a1
8
nr4a1 regulates
8
regulates winter
8
behavior medaka
8
behavior winter
8
medaka brain
8

Similar Publications

Pain and pain-related psychiatric diseases affect approximately one-third of the global population, and effective treatment remains a lack of options. NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome is regarded as a potential therapeutic target for managing pain and related psychiatric diseases. Our previous research reported that 1,2,4-trimethoxybenzene (1,2,4-TTB) effectively inhibited NLRP3 inflammasome activity.

View Article and Find Full Text PDF

β-Glucan, a polysaccharide from Saccharomyces cerevisiae with immunomodulatory activities that may not trigger pro-inflammatory responses in microglia, has been reported to show rapid antidepressant effects in chronically stressed animals by restoring microglial function in the dentate gyrus. However, the mechanisms underlying this effect of β-glucan are still largely unclear. Considering the importance of astrocytic purinergic 2Y1 receptors (P2Y1Rs) and brain-derived neurotrophic factor (BDNF) in the antidepressant effects of microglial stimulation, we hypothesize that β-glucan produces antidepressant effects by mobilizing astrocytic P2Y1R-triggered BDNF signaling in the hippocampus.

View Article and Find Full Text PDF

Network pharmacology-guided lipidomics and molecular docking reveals the involvement of sphingolipid metabolism and HIF-1 signaling in Xiaoyao San's blood-nourishing mechanism against depression.

J Ethnopharmacol

September 2025

Modern Research Center for Traditional Chinese Medicine of Shanxi University, Taiyuan, Shanxi, 030006, China; Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Taiyuan, Shanxi, 030006, China; Key Laboratory of Effective Substances Research and Utilization in TCM

Ethnopharmacological Relevance: Depression is a common psychiatric disorder and has become a growing public health issue. In the traditional Chinese medicine (TCM) clinic, blood deficiency is a common syndrome pattern in depression. Xiaoyao San (XYS), a classic formula with the property of nourishing blood, is widely used to treat depression.

View Article and Find Full Text PDF

Limosilactobacillus reuteri-butyrate axis in depression therapy: A key pathway discovered through a novel preclinical human flora-associated animal model.

Pharmacol Res

September 2025

School of Pharmacy, Second Military Medical University, Shanghai 200433, China; Shanghai Key Laboratory for Pharmaceutical Metabolite Research, School of Pharmacy, Second Military Medical University, Shanghai 200433, China. Electronic address:

The transition from preclinical to clinical drug development is critically impeded by interspecies disparities, which limit the predictive validity of preclinical efficacy for human outcomes. To address this limitation, we established a human flora-associated depression rat (HFADR) model through fecal microbiota transplantation (FMT). The HFADR model bridges the preclinical-clinical translation by recapitulating conserved microbial-host interactions identified through multi-omics analysis in a chronic unpredictable mild stress (CUMS) rat model and in patients with major depressive disorder.

View Article and Find Full Text PDF

Engineered VTA dopaminergic neurons offer a new path to treating depression.

Cell Stem Cell

September 2025

Department of Psychology, Sapienza University, via dei Marsi 78, 00185 Rome, Italy; IRCCS San Raffaele, via di Val Cannuta 247, 00166 Rome, Italy. Electronic address:

Dysfunction of A10 midbrain dopaminergic (mDA) neurons is linked to psychiatric disorders, such as depression. In this issue, Yan et al. present an efficient method for differentiating human pluripotent stem cells into A10-like mDA neurons.

View Article and Find Full Text PDF